Skip to main content

Refine your results

Filters
Date
Displaying 141 - 160 of 199

Statement of Commissioner Rebecca Kelly Slaughter in the Matter of Liberty Chevrolet, Inc. d/b/a Bronx Honda

In the Matter of Liberty Chevrolet, Inc. d/b/a Bronx Honda
Date
Matter Number

162 3238

By
Rebecca Kelly Slaughter, Commissioner
Related Releases
Auto Dealership Bronx Honda, General Manager to Pay $1.5 Million to Settle FTC Charges They Discriminated Against African-American, Hispanic Car Buyers

Concurring Statement of Commissioner Rebecca Kelly Slaughter in the Matter of Shop Tutors, Inc. d/b/a LendEDU

In the Matter of Shop Tutors, Inc. d/b/a LendEDU
Washington, D.C.
Date
Matter Number

182 3180

By
Rebecca Kelly Slaughter, Commissioner
Related Releases
Operators of Comparison Shopping Website Agree to Settle FTC Charges Alleging Deceptive Rankings of Financial Products and Fake Reviews

Concurring Statement of Commissioner Rebecca Kelly Slaughter in Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady

Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady
Date
By
Rebecca Kelly Slaughter, Commissioner
Related Releases
FTC and NY Attorney General Charge Vyera Pharmaceuticals, Martin Shkreli, and Other Defendants with Anticompetitive Scheme to Protect a List-Price Increase of More Than 4,000 Percent for Life-Saving Drug Daraprim

Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics

In the matter of Roche Holding/Spark Therapeutics
Date
Matter Number

191 0086

By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rohit Chopra, Former Commissioner;
Rebecca Kelly Slaughter, Commissioner;
Christine S. Wilson, Former Commissioner
Related Releases
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.

Concurring Statement of Commissioner Rebecca Kelly Slaughter In the Matter of the University of Phoenix, Inc.

Washington, D.C.
Date
Matter Number

152 3231

By
Rebecca Kelly Slaughter, Commissioner
Related Releases
FTC Obtains Record $191 Million Settlement from University of Phoenix to Resolve FTC Charges It Used Deceptive Advertising to Attract Prospective Students

Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation

Washington, D.C.
Date
Matter Number

191 0061

Docket Number
C-4690
By
Rebecca Kelly Slaughter, Commissioner
Related Releases
FTC Requires Bristol-Myers Squibb Company and Celgene Corporation to Divest Psoriasis Drug Otezla as a Condition of Acquisition
FTC Approves Modifications to Bristol Meyers Squibb Divestiture Agreement
Displaying 141 - 160 of 199

Join us at the FTC!

View our open positions

Return to top